Ready to Lead New dean at Michigan State University College of Osteopathic Medicine Three-time MSU alumnus Andrea Amalfitano, DO, will lead COM in research, student support and curriculum revision. Dec. 17, 2018Monday AOA Staff Contact AOA Staff Facebook Twitter LinkedIn Email Topics deangene transfermicrobiology On Dec. 14, Andrea Amalfitano, DO, became dean of Michigan State University College of Osteopathic Medicine (MSUCOM). He has served as the COM’s interim dean since February. “I can’t imagine a greater honor than leading the college that gave me my start in osteopathic medicine,” Amalfitano said in a MSUCOM press release. “I plan to focus on building an even better student experience, strengthening our already impressive faculty research portfolio and working with our colleagues in the university’s health colleges to provide exceptional clinical care.” Dr. Amalfitano is a three-time alumnus of Michigan State University; he has a bachelor of science degree and PhD in microbiology from the university, as well as a DO degree from MSUCOM. The focus of Dr. Amalfitano’s research has centered on clinical medicine and applied genetics related to gene transfer to treat diseases in infants, children and adults including lethal muscular dystrophies, cancer, autism and autoimmune disorders. In a statement, MSU Provost June Pierce Youatt said Dr. Amalfitano is “eager to take on the challenges of curriculum revision, enhance student support, expand the college’s research agenda, and create deeper relationships with our hospital partners.” Prior to his current role, Dr. Amalfitano served as director of MSU’s Clinical and Translational Sciences Institute and a professor of microbiology and molecular genetics and pediatrics at MSU. For further reading: DO elected to leadership position on ACGME Board of Directors DO’s wellness project bring health education to Flint, Michigan More in Newsbriefs Free holistic residency application review platform will soon be available for residency programs that use ERAS Cortex, an AI-enabled platform, is designed to provide technology-assisted holistic review by streamlining application screening and review. AOA’s research grants workshop will guide applicants through funding process The Nov. 14 workshop will cover important topics such as RFA/NOFOs and available funding amounts. Previous articleGrey's Anatomy, Seinfeld, and DO tattoos: Top pop culture and lifestyle stories Next articleMoney tips for each step of your medical journey
Free holistic residency application review platform will soon be available for residency programs that use ERAS Cortex, an AI-enabled platform, is designed to provide technology-assisted holistic review by streamlining application screening and review.
AOA’s research grants workshop will guide applicants through funding process The Nov. 14 workshop will cover important topics such as RFA/NOFOs and available funding amounts.